MASHINIi

Biote Corp..

BTMD.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products

Biote Corp. is a U.S.-based company focused on hormone optimization through subcutaneous hormone pellet therapy. They provide training, education, and certification for medical practitioners to administer Biote Method, a personalized approach to hormone replacement therapy. The company also offers n...Show More

Ethical Profile

Mixed.

Biote Corp.'s ethical standing presents a mixed picture, primarily due to significant concerns regarding patient safety and transparency. The FDA cited BioTE Medical for allegedly failing to report over 4,022 adverse events linked to its personalized hormone drugs, raising questions about risk disclosure. While the company claims a low complication rate of less than 1% for its subcutaneous pellet therapy, the unreported events challenge the reliability of this data. Critics also point to potential risks associated with bioidentical hormones, including blood clots and heart disease. Information on areas like fair pay, ethical sourcing, and environmental impact is largely unavailable, making a comprehensive assessment difficult.

Value Scores

Better Health for All-60
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business0
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

-60

Biote Medical failed to report over 4,022 adverse events related to its personalized hormone drugs to the FDA between 2013 and 2018, despite having an online portal to collect this information.

1
The FDA cited the company for this failure on September 9, 2023, noting that BioTE Medical was not registered as an outsourcing facility.
2
The company's own data from 2012-2019 reported an overall complication rate from subcutaneous pellet therapy as <1%.
3
Bioidentical hormones carry risks including blood clots, stroke, gallbladder disease, heart disease, and breast cancer, particularly with prolonged use, and compounded versions lack FDA testing and oversight.
4
Biote focuses on hormone optimization and preventative medicine, citing studies on testosterone's potential breast cancer protective effect and hormone therapy's potential role in delaying dementia.
5
The company trains 6,400 U.S. healthcare providers on hormone optimization and aims to educate men and healthcare professionals about hormonal imbalances.
6

Fair Money & Economic Opportunity

0

No evidence available to assess Biote Corp. on Fair Money & Economic Opportunity.

Fair Pay & Worker Respect

0

No specific, quantitative data points were found in the provided articles for any of the Fair Pay & Worker Respect KPIs for Biote Corp. Information regarding employee benefits, such as health insurance and 401(k) plans, was anecdotal from employee reviews and company responses, lacking quantitative coverage percentages.

1
Surveys on women in the workplace focused on menopause symptoms and general workforce trends, not specific employee engagement or turnover rates for Biote Corp.
2
Salary data was an estimate from a proprietary algorithm, without details on living wage coverage.
3
There was no information on CEO-median pay ratio, collective bargaining, safety incident rates, pay equity, labor violations, or insecure contract share for the company.
4

Fair Trade & Ethical Sourcing

0

No evidence was found in the provided articles regarding Biote Corp.'s performance on fair trade and ethical sourcing practices.

1
The articles focus on quality control procedures for hormone pellet production and provider certification, without addressing supply chain certifications, audits, labor incidents, traceability, remediation, ethical clauses in contracts, material risk, or supplier diversity spend.
2

Honest & Fair Business

0

No evidence available to assess Biote Corp. on Honest & Fair Business.

Kind to Animals

0

No specific, concrete data points were found in the provided articles regarding BTMD.US's practices or policies related to animal welfare.

1
The articles did not contain information on cruelty-free certifications, animal testing, humane certifications for operations, wildlife conservation impact, ethical ingredient substitution, supplier audits for welfare, cage-free sourcing, animal testing policies or volume, R&D investment in animal-free technologies, animal agriculture ethics, animal-free R&D collaboration, or public policy engagement on animal welfare.
2

No War, No Weapons

0

No specific, concrete evidence was found in the provided articles regarding BTMD.US's association with arms manufacturing, military contracts, dual-use technologies, or any other metrics related to the 'No War, No Weapons' ethical value. The articles discuss general industry trends, regulatory changes for laboratory instruments

1
, and export control policies
2
, but do not provide company-specific data for BTMD.US.
3

Planet-Friendly Business

0

No evidence available to assess Biote Corp. on Planet-Friendly Business.

Respect for Cultures & Communities

0

No evidence available to assess Biote Corp. on Respect for Cultures & Communities.

Safe & Smart Tech

0

Biote Corp. employs standard security measures, including data encryption via SSL protocol for web browser communications and 2-factor authentication.

1
The company maintains policies and processes for assessing and managing cybersecurity risks, which include routine risk assessments, system audits, and third-party assessments.
2
User data control is provided through opt-out options for marketing communications and the ability to request data access.
3
The company's privacy policy mentions data retention for active accounts and legal obligations, and it complies with California Civil Code Section 1798.83 (Shine the Light law).
4

Zero Waste & Sustainable Products

0

No specific, quantitative data or concrete actions related to BTMD.US's performance on any of the 'Zero Waste & Sustainable Products' KPIs are provided across the articles. The available articles discuss general industry trends, sustainable packaging options, and overall ESG risk ratings for BTMD.US, but they do not offer company-specific metrics or initiatives for waste diversion, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design, waste reduction initiatives, hazardous waste management, product durability, repairability, waste audit frequency, zero-waste certification, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education.

1

Own Biote Corp.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.